Treatment of melasma: a review of less commonly used antioxidants

被引:23
作者
Babbush, Kayla M. [1 ]
Babbush, Remy A. [2 ]
Khachemoune, Amor [3 ,4 ]
机构
[1] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Div Dermatol, Bronx, NY 10467 USA
[2] Cornell Univ, Dept Food Sci, Ithaca, NY 14853 USA
[3] State Univ New York Downstate, Dept Dermatol, Brooklyn, NY 11209 USA
[4] Vet Hlth Adm, Dept Dermatol, Brooklyn, NY USA
关键词
D O I
10.1111/ijd.15133
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Melasma, a common cause for seeking dermatologic care, is a chronic condition of skin hyperpigmentation. With a poorly understood pathogenesis, and no universal cure, melasma is a challenge for many dermatologists. For decades, there has been investigation into the role of oxidative stress in melasma. In this literature review, we introduce the role of oxidative stress in melasma and discuss the function of various topical and oral antioxidant therapies for patients suffering from melasma. Numerous studies have shown efficacy of various antioxidant therapies for treatment of hyperpigmentation, and in this review, we focus primarily on those with less widespread use. Vitamin E, niacinamide, polypodium leucotomos, pycnogenol, grape seed extract, amino fruit acids, phytic acid, zinc, silymarin, Korean red ginseng powder, plant extracts, and parsley all have well-demonstrated evidence of antioxidant properties, and these substances have been studied in the context of skin hyperpigmentation. Although there is conflicting evidence of their therapeutic efficacy, the use of these naturally occurring substances is promising for patients and medical providers seeking alternative therapeutic options.
引用
收藏
页码:166 / 173
页数:8
相关论文
共 103 条
[1]  
ABOUTEINIEN MH, 2020, J LIPOSOME RES, V0030, P00054, DOI DOI 10.1080/08982104.2019.1585448
[2]  
ADDOR FAS, 2017, AN BRAS DERMATOL, V0092, P00356, DOI DOI 10.1590/ABD1806-4841.20175697
[3]  
AHMED AM, 2013, JAMA DERMATOL, V0149, P00981, DOI DOI 10.1001/JAMADERMATOL.2013.4294
[4]  
ALMOKADEM S, 2013, EDYPT J DERMATOL VEN, V0033, P00006
[5]  
ALTAEI T, 2012, BMC DERMATOL, V0012, DOI DOI 10.1186/1471-5945-12-18
[6]  
ARJINPATHANA N, 2012, J DERMATOL TREAT, V0023, P00097, DOI DOI 10.3109/09546631003801619
[7]  
Armstrong D, 2016, OXIDATIVE STRESS ANT
[8]  
Babbush KM, 2020, J DRUGS DERMATOL, V19, P788
[9]  
BAEK J, 2016, REDOX REP, V0021, P00164, DOI DOI 10.1179/1351000215Y.0000000015
[10]  
BAGCHI D, 2000, TOXICOLOGY, V0148, P00187